子宫癌女性临终关怀与医疗支出趋势
该观察性队列研究利用SEER-Medicare关联数据库,纳入2000至2011年死于子宫癌的65岁以上女性5873例,分析临终前一个月高强度医疗利用及费用。42.5%接受高强度医疗,中位Medicare支出为7645美元,接受高强度医疗者支出中位数为未接受者的4倍。
要点
- 42.5%的子宫癌女性在临终前一个月接受高强度医疗。
- 高强度医疗者临终前一个月中位支出为16173美元,未接受者为4099美元。
- 高强度医疗比例在研究期间保持稳定。
核心结论
- 在子宫癌女性中,临终前一个月高强度医疗常见,与大量医疗支出相关,且未见减少。
研究设计与样本
- 观察性队列研究,使用SEER-Medicare关联数据库识别2000年至2011年死于子宫癌的65岁以上女性,共5873例。
主要发现
- 5873例患者中,42.5%接受高强度医疗。
- 临终前一个月内,15.0%有≥2次住院,9.0%住院超过14天,15.3%有>1次急诊就诊,18.3%入住ICU,6.6%在生命最后14天接受化疗。
- 高强度医疗比例在研究期间保持稳定。
- 临终前一个月中位Medicare支出为7645美元;总人均支出从2000年的9656美元(四分位距3190-15890)到2011年的9208美元(四分位距3309-18554)保持稳定。
- 接受高强度医疗者中位支出为16173美元,未接受者为4099美元,前者约为后者的4倍。
关键数值与推荐
- 高强度医疗定义为以下任一:≥2次住院、>1次急诊就诊、≥1次ICU入住、或生命最后14天内使用化疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High-intensity care including hospitalizations, chemotherapy, and other interventions at the end of life is costly and often of little value for cancer patients. Little is known about patterns of end-of-life care and resource utilization for women with uterine cancer. OBJECTIVE: We examined the costs and predictors of aggressive end-of-life care for women with uterine cancer. STUDY DESIGN: In this observational cohort study the Surveillance, Epidemiology, and End Results-Medicare linked database was used to identify women age ≥65 years who died from uterine cancer from 2000 through 2011. Resource utilization in the last month of life including ≥2 hospital admissions, >1 emergency department visit, ≥1 intensive care unit admission, or use of chemotherapy in the last 14 days of life was examined. High-intensity care was defined as the occurrence of any of the above outcomes. Logistic regression models were developed to identify factors associated with high-intensity care. Total Medicare expenditures in the last month of life are reported. RESULTS: Of the 5873 patients identified, the majority had stage IV cancer (30.2%), were white (79.9%), and had endometrioid tumors (47.6%). High-intensity care was rendered to 42.5% of women. During the last month of life, 15.0% had ≥2 hospital admissions, 9.0% had a hospitalization >14 days, 15.3% had >1 emergency department visits, 18.3% had an intensive care unit admission, and 6.6% received chemotherapy in the last 14 days of life. The percentage of women who received high-intensity care was stable over the study period. Characteristics of younger age, black race, higher number of comorbidities, stage IV disease, residence in the eastern United States, and more recent diagnosis were associated with high-intensity care. The median Medicare payment during the last month of life was $7645. Total per beneficiary Medicare payments remained stable from $9656 (interquartile range $3190-15,890) in 2000 to $9208 (interquartile range $3309-18,554) by 2011. The median health care expenditure was 4 times as high for those who received high-intensity care compared to those who did not (median $16,173 vs $4099). CONCLUSION: Among women with uterine cancer, high-intensity care is common in the last month of life, associated with substantial monetary expenditures, and does not appear to be decreasing.
引用
- Margolis B, Chen L, Accordino MK, et al. Trends in end-of-life care and health care spending in women with uterine cancer. Am J Obstet Gynecol. 2017. PMID: 28709581. doi:10.1016/j.ajog.2017.07.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。